News

Ophthalmology Times12h
Nicox completes phase 3 Denali trial of NCX 470 in open-angle glaucoma or ocular hypertension
Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...
Healio2d
‘This boggled my mind’: Lacrifill occlusion improves ocular surface inflammation
MINNEAPOLIS — Lacrifill, a canalicular gel for patients with dry eye, improves ocular surface inflammation, including in ...
Soy Carmín on MSN3d
The 30-Second Spark: How Emotionally Intelligent People Nail First Impressions, According to Science
In a world where snap judgments are common, emotionally intelligent individuals possess a powerful secret weapon: they master ...
Biotech's treatment shows promise for age-related vision loss
Triangle gains public company with merger Breakthrough! RTP biotech sees progress in restoring vision to blind Breakthrough!
Opus Genetics Announces VEGA-3 Phase 3 Trial Met Its Primary Endpoint For Phentolamine Ophthalmic Solution 0.75% For The Treatment Of Presbyopia
Study met its primary and key secondary endpoints, demonstrating rapid and sustained improvement in near visual acuity <li /> Safety pr ...
GOLDINVEST.de5d
Goliath Resources turns up the heat: Gold drilling program to be expanded to up to 60,000 meters!
The original drilling plans for the Surebet gold discovery, recently presented by Goliath Resources (WKN A2P063 / TSXV GOT), ...
From Retinal Scans to Cancer Genomics: Public AI Healthcare Plays You Shouldn’t Ignore
Baystreet.ca News Commentary – As populations age and chronic illnesses become more widespread, healthcare systems around the world are being pushed to their limits. But a ...